Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ESMO Sarcoma and Rare Cancers Congress 2023

20 - 22 Mar 2023

Lugano, Switzerland

ESMO-Sarcoma&RareCancers-1000x1000px

Presentations (slides) and webcasts are available to ESMO Members and registered delegates according to the presenters' agreement to release them.

The copyright protected educational resources from this event are for personal usage only and not to be shared with any third parties. ESMO thanks the authors for their generosity.

The Programme provided insights into the diagnosis, prognostication, management and ongoing research of patients with rare adult solid cancers. Educational and scientific sessions covered State-of-the-art multidisciplinary management of patients affected by the 10 families of rare solid tumours, insights into the biology, molecular classification and diagnostics of sarcomas and rare cancers, and latest research data focusing on precision therapeutics for rare cancers and some rare molecular subgroups of common cancers.

All resources are published!

Use the search box below to type any keywords, or abstract numbers.

Hide
Filter by:

There are 286 resources available

Invited discussant

Presenter: Lynnette Fernandez-Cuesta

Session: Proffered paper session – Rare Cancers

Resources:

Slides

Webcast

Q&A and discussion

Presenter: Sophie Piperno-Neumann

Session: Non-skin melanoma, adnexal tumours and Merkel cell carcinoma

Resources:

Webcast

Q&A

Presenter: Antonia Digklia

Session: Proffered paper session – Rare Cancers

Resources:

Webcast

Introduction and first vote

Presenter: Annalisa Trama

Session: Is HTA (Health Technology Assessment) applicable to rare cancers?

Resources:

Webcast

Pro

Presenter: Cesar Serrano

Session: Is HTA (Health Technology Assessment) applicable to rare cancers?

Resources:

Slides

Webcast

Con

Presenter: Jean-Yves Blay

Session: Is HTA (Health Technology Assessment) applicable to rare cancers?

Resources:

Slides

Webcast

Second vote and conclusions

Presenter: Annalisa Trama

Session: Is HTA (Health Technology Assessment) applicable to rare cancers?

Resources:

Webcast

Introduction

Presenter: Carol Swallow

Session: What to do after whoops surgery of soft tissue sarcoma (STS)

Resources:

Webcast

Introduction

Presenter: Alfredo Berruti

Session: Management of GEP NENs

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.